Deutsch
Español
India
Italiano
Français
My Account
My Account
Notifications
Overview
+ New Watchlist
Benzinga Research
Benzinga Pro
Log In
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
Get Benzinga Pro
Data & APIs
Events
Marketfy
Premarket
Boost
Advertise
Contribute
Deutsch
Español
India
Italiano
Français
Sign in
Our Services
News
Earnings
Guidance
Dividends
M&A
Buybacks
Legal
Interviews
Management
Offerings
IPOs
Insider Trades
Biotech/FDA
Politics
Government
Healthcare
Markets
Pre-Market
After Hours
Movers
ETFs
Forex
Cannabis
Commodities
Options
Binary Options
Bonds
Futures
CME Group
Global Economics
Previews
Small-Cap
Real Estate
Cryptocurrency
Penny Stocks
Digital Securities
Volatility
Ratings
Analyst Color
Downgrades
Upgrades
Initiations
Price Target
Ideas
Trade Ideas
Covey Trade Ideas
Long Ideas
Short Ideas
Technicals
From The Press
Jim Cramer
Rumors
Best Stocks & ETFs
Best Penny Stocks
Best S&P 500 ETFs
Best Swing Trade Stocks
Best Blue Chip Stocks
Best High-Volume Penny Stocks
Best Small Cap ETFs
Best Stocks to Day Trade
Best REITs
Money
Investing
Cryptocurrency
Mortgage
Insurance
Yield
Personal Finance
Forex
Startup Investing
Real Estate Investing
Credit Cards
Crypto
Cannabis
Cannabis Conference
News
Earnings
Interviews
Deals
Regulations
Psychedelics
Jobs
Markets
Pre-Market
After Hours
Movers
ETFs
Forex
Cannabis
Commodities
Options
Binary Options
Bonds
Futures
CME Group
Global Economics
Previews
Small-Cap
Real Estate
Cryptocurrency
Penny Stocks
Digital Securities
Volatility
Ratings
Analyst Color
Downgrades
Upgrades
Initiations
Price Target
Ideas
Trade Ideas
Covey Trade Ideas
Long Ideas
Short Ideas
Technicals
From The Press
Jim Cramer
Rumors
Best Stocks & ETFs
Best Penny Stocks
Best S&P 500 ETFs
Best Swing Trade Stocks
Best Blue Chip Stocks
Best High-Volume Penny Stocks
Best Small Cap ETFs
Best Stocks to Day Trade
Best REITs
Money
Investing
Cryptocurrency
Mortgage
Insurance
Yield
Personal Finance
Forex
Startup Investing
Real Estate Investing
Credit Cards
Crypto
Cannabis
Cannabis Conference
News
Earnings
Interviews
Deals
Regulations
Psychedelics
Jobs
Research
My Stocks
Tools
Free Benzinga Pro Trial
Calendars
Analyst Ratings Calendar
Conference Call Calendar
Dividend Calendar
Earnings Calendar
Economic Calendar
FDA Calendar
Guidance Calendar
IPO Calendar
M&A Calendar
SPAC Calendar
Stock Split Calendar
Trade Ideas
Free Stock Reports
Insider Trades
Trade Idea Feed
Analyst Ratings
Unusual Options Activity
Heatmaps
Free Newsletter
Government Trades
Short Interest
Most Shorted
Largest Increase
Largest Decrease
Calculators
Margin Calculator
Forex Profit Calculator
100x Options Profit Calculator
Recent
Markets
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
Profound Medical
(NASDAQ:PROF)
Intraday
$8.03
0.33
[4.29%]
After-Hours
$8.03
0
[0.00%]
Get Report
Watch
Perks
Buy
Compare Brokers
$8.03
0.33
[4.29%]
At close: Apr 12
$8.03
0
[0.00%]
After Hours: 9:30AM EDT
Get Report
Watch
Q1 2024 Earnings in 14 days from now on Thu May 9th, after the market close
Overview
News
Earnings
Guidance
Dividends
Analyst Ratings
Insider Trades
Short Interest
Latest News for Profound Medical Stock (NASDAQ:PROF)
Profound Medical Stock (NASDAQ: PROF)
Categories: All
All News
General
Contracts
Dividends
Events
FDA
M&A
Offerings
Stock Split
Media
Buybacks
Insider Trades
Earnings
Guidance
Analyst Ratings
Trading Ideas
All News
General
Contracts
Dividends
Events
FDA
M&A
Offerings
Stock Split
Media
Buybacks
Insider Trades
Earnings
Guidance
Analyst Ratings
Trading Ideas
Monday, March 11, 2024
Alliance Global Partners Maintains Buy on Profound Medical, Lowers Price Target to $10.8
Benzinga Newsdesk
-
Mar 11, 2024, 10:33AM
Friday, March 08, 2024
Stifel Maintains Hold on Profound Medical, Lowers Price Target to $9
Benzinga Newsdesk
-
Mar 8, 2024, 10:45AM
Thursday, March 07, 2024
Profound Medical: Q4 Earnings Insights
Benzinga Insights
-
Mar 7, 2024, 4:20PM
Profound Medical Q4 2023 GAAP EPS $(0.420) Misses $(0.330) Estimate, Sales $2.000M Beat $1.977M Estimate
Benzinga Newsdesk
-
Mar 7, 2024, 4:19PM
Earnings Scheduled For March 7, 2024
Benzinga Insights
-
Mar 7, 2024, 4:49AM
Tuesday, January 16, 2024
Profound Medical Announces Non-Brokered Private Placement For Gross Proceeds Of ~$2,937,507; Expects To Issue 391,667 Common Shares At $7.50/Share
Benzinga Newsdesk
-
Jan 16, 2024, 4:32PM
Thursday, January 04, 2024
Alliance Global Partners Maintains Buy on Profound Medical, Lowers Price Target to $12.75
Benzinga Newsdesk
-
Jan 4, 2024, 9:05AM
Wednesday, January 03, 2024
Profound Medical Announces Preliminary Unaudited Q4 And FY23 Revenues; Sees Q4 Revenue $1.9M-$2M Vs $2.02M Est.; FY23 Revenue $7.1M-$7.2M Vs $7.22M Est.
Benzinga Newsdesk
-
Jan 3, 2024, 4:20PM
Thursday, December 28, 2023
Chord Energy, Profound Medical And 3 Stocks To Watch Heading Into Thursday
Avi Kapoor
-
Dec 28, 2023, 4:24AM
Profound Medical Prices $20M Public Offering Of 2,666,667 Common Shares At $7.50/Share
Benzinga Newsdesk
-
Dec 28, 2023, 1:56AM
Wednesday, December 27, 2023
Profound Medical Announces Proposed Public Offering Of Common Shares; Terms Not Disclosed
Benzinga Newsdesk
-
Dec 27, 2023, 4:18PM
Tuesday, November 28, 2023
Stifel Initiates Coverage On Profound Medical with Hold Rating, Announces Price Target of $11
Benzinga Newsdesk
-
Nov 28, 2023, 4:22AM
Friday, November 03, 2023
Profound Medical Announces CMS Extension Of Temporary 'Code' For TULSA To ASC Setting; To Go Into Effect Jan. 1, 2024
Benzinga Newsdesk
-
Nov 3, 2023, 8:09AM
Thursday, November 02, 2023
Profound Medical Q3 EPS $(0.26) Beats $(0.34) Estimate, Sales $1.73M Miss $2.06M Estimate
Benzinga Newsdesk
-
Nov 2, 2023, 4:17PM
Earnings Scheduled For November 2, 2023
Benzinga Insights
-
Nov 2, 2023, 4:56AM
Tuesday, September 26, 2023
TD SYNNEX, Profound Medical And 3 Stocks To Watch Heading Into Tuesday
Lisa Levin
-
Sep 26, 2023, 4:18AM
Monday, September 25, 2023
Profound Medical Secures FDA 510(k) Clearance For TULSA-PRO Thermal Boost
Benzinga Newsdesk
-
Sep 25, 2023, 4:06PM
Thursday, September 07, 2023
Profound Medical Initiates Up To $30M At-The-Market Offering
Benzinga Newsdesk
-
Sep 7, 2023, 1:35AM
Wednesday, August 09, 2023
Profound Medical Q2 EPS $(0.35) Misses $(0.34) Estimate, Sales $1.60M Miss $2.17M Estimate
Benzinga Newsdesk
-
Aug 9, 2023, 4:56PM
Earnings Scheduled For August 9, 2023
Benzinga Insights
-
Aug 9, 2023, 4:54AM
Friday, August 04, 2023
Benzinga's Top Ratings Upgrades, Downgrades For August 4, 2023
Benzinga Insights
-
Aug 4, 2023, 11:01AM
Raymond James Downgrades Profound Medical to Outperform
Benzinga Newsdesk
-
Aug 4, 2023, 8:49AM
Thursday, May 11, 2023
TD Cowen Maintains Outperform on Profound Medical, Raises Price Target to $18
Benzinga Newsdesk
-
May 11, 2023, 7:17AM
Alliance Global Partners Maintains Buy on Profound Medical, Raises Price Target to $15.75
Benzinga Newsdesk
-
May 11, 2023, 6:48AM
Wednesday, May 10, 2023
Profound Medical: Q1 Earnings Insights
Benzinga Insights
-
May 10, 2023, 5:15PM
Profound Medical Q1 EPS $(0.32) Beats $(0.34) Estimate, Sales $1.86M Miss $2.11M Estimate
Michael Horton
-
May 10, 2023, 4:09PM
Earnings Scheduled For May 10, 2023
Benzinga Insights
-
May 10, 2023, 9:12AM
Tuesday, March 21, 2023
Benzinga's Top Ratings Upgrades, Downgrades For March 21, 2023
Benzinga Insights
-
Mar 21, 2023, 11:00AM
Jefferies Downgrades Profound Medical to Equal-Weight, Raises Price Target to $10
Benzinga Newsdesk
-
Mar 21, 2023, 5:38AM
Tuesday, March 07, 2023
Profound Medical Q4 EPS $(0.46) Misses $(0.36) Estimate, Sales $1.30M Miss $2.72M Estimate
Happy Mohamed
-
Mar 7, 2023, 4:10PM
Earnings Scheduled For March 7, 2023
Benzinga Insights
-
Mar 7, 2023, 4:37AM
Monday, March 06, 2023
Earnings Preview For Profound Medical
Benzinga Insights
-
Mar 6, 2023, 11:01AM
Friday, November 04, 2022
Raymond James Upgrades Profound Medical to Strong Buy
Benzinga Newsdesk
-
Nov 4, 2022, 2:55PM
Profound Medical shares are trading higher after the company reported better-than-expected Q3 EPS results.
Michael Horton
-
Nov 4, 2022, 12:00PM
Thursday, November 03, 2022
Profound Medical Q3 EPS $(0.24) Beats $(0.38) Estimate, Sales $2.04M Miss $2.35M Estimate
Benzinga Newsdesk
-
Nov 3, 2022, 4:10PM
Earnings Scheduled For November 3, 2022
Benzinga Insights
-
Nov 3, 2022, 5:42AM
Friday, October 21, 2022
Stocks That Hit 52-Week Lows On Friday
Benzinga Insights
-
Oct 21, 2022, 1:26PM
Wednesday, October 19, 2022
Stocks That Hit 52-Week Lows On Wednesday
Benzinga Insights
-
Oct 19, 2022, 12:54PM
Tuesday, October 11, 2022
Stocks That Hit 52-Week Lows On Tuesday
Benzinga Insights
-
Oct 11, 2022, 12:47PM
Monday, October 10, 2022
Stocks That Hit 52-Week Lows On Monday
Benzinga Insights
-
Oct 10, 2022, 12:29PM
Wednesday, October 05, 2022
Stocks That Hit 52-Week Lows On Wednesday
Benzinga Insights
-
Oct 5, 2022, 12:43PM
Monday, September 26, 2022
Profound Medical Highlights Four Year Follow-Up Data From TACT Pivotal Clinical Trial
Bill Haddad
-
Sep 26, 2022, 8:01AM
Wednesday, September 21, 2022
Stocks That Hit 52-Week Lows On Wednesday
Benzinga Insights
-
Sep 21, 2022, 12:42PM
Monday, September 19, 2022
Stocks That Hit 52-Week Lows On Monday
Benzinga Insights
-
Sep 19, 2022, 12:30PM
Friday, September 16, 2022
Stocks That Hit 52-Week Lows On Friday
Benzinga Insights
-
Sep 16, 2022, 2:08PM
Thursday, September 15, 2022
Stocks That Hit 52-Week Lows On Thursday
Benzinga Insights
-
Sep 15, 2022, 1:03PM
Tuesday, September 13, 2022
Stocks That Hit 52-Week Lows On Tuesday
Benzinga Insights
-
Sep 13, 2022, 1:48PM
Thursday, September 08, 2022
Stocks That Hit 52-Week Lows On Thursday
Benzinga Insights
-
Sep 8, 2022, 12:08PM
Wednesday, September 07, 2022
Stocks That Hit 52-Week Lows On Wednesday
Benzinga Insights
-
Sep 7, 2022, 1:08PM
Tuesday, September 06, 2022
Stocks That Hit 52-Week Lows On Tuesday
Benzinga Insights
-
Sep 6, 2022, 1:42PM
Show more
